Remove Follow-Up Remove Medication Remove Tests
article thumbnail

This Startup Built A Hospital In India To Test Its AI Software

Forbes Healthcare

Senior editor covering healthcare Follow Author Jul 01, 2025, 06:30am EDT Updated Jul 1, 2025, 10:33am EDT Share Save Comment New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

article thumbnail

The Most Expensive Medical Condition Is Not What You Think

Forbes Healthcare

Follow Author Jul 11, 2025, 08:30am EDT Share Save Comment Million Dollars Seamless Pattern with USD Dollar Sign. Follow Author Jul 11, 2025, 08:30am EDT Share Save Comment Million Dollars Seamless Pattern with USD Dollar Sign. Forbes contributors publish independent expert analyses and insights. Raining money stack grunge background.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

These 3 Medical Trends Predict A Massive Healthcare Crisis

Forbes Healthcare

Advertise with Forbes Forbes Licensing & Syndication Report a Security Issue Editorial Values and Standards Site Feedback Contact Us Careers at Forbes Tips Corrections Privacy Do Not Sell My Personal Information Terms AdChoices Reprints & Permissions These 3 Medical Trends Predict A Massive Healthcare Crisis By Robert Pearl, M.D.

article thumbnail

When Nothing is Something

Sensible Medicine

When he came into my office last week and told me about this case, announcing that “sometimes, the best thing you can do for a patient is nothing,” I immediately asked him to write it up for Sensible Medicine. An X-ray or a simple blood test? In this environment, test results come back not in days or weeks, but hours.

article thumbnail

A review of the newly approved novel non-opioid pain reliever suzetrigine (Journavx)

Sensible Medicine

Last week the FDA approved a novel non-opioid pain medication. A Google search brings up news releases from Vertex , and news coverage—which are essentially the same and lacking links to the evidence. Second, a new pain medication would serve a huge unmet need, because many people begin opioid addition from a post-op opioid.

article thumbnail

A Standing Ovation for CHALLENGE

Sensible Medicine

I read with interest the detailed critique of the recently presented and published CHALLENGE trial offered up by Mandrola and Cifu. As an academic colorectal oncologist with 20 years of experience, I have closely followed the developments in research on the effects of exercise on colon cancer outcomes. Mandrola and Cifu.

article thumbnail

Rewriting Genetic Fate: Universal Newborn Genomic Screening Arrives

Forbes Healthcare

Haseltine Follow Author Share Save Comment Innovation Healthcare Rewriting Genetic Fate: Universal Newborn Genomic Screening Arrives By William A. Haseltine , Contributor. Forbes contributors publish independent expert analyses and insights. Haseltine, Ph.D.,